Product Information
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $3924.3531 per ML under NDC 00078063998. Its NADAC has been published 114 times since Jun 19, 2024.
Strength
150 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078063998
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
SECUKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125504On Market Since
1/21/2015
Pharmacological Classes
Price Statistics
The NADAC for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES has been published 114 times since Jun 19, 2024, and over the history we have for it it has risen 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3924.3531 per ML |
|---|---|
| All-time high | $3965.6440 (Jul 15, 2026) |
| All-time low | $3579.9043 (Jun 19, 2024) |
| 52-week high | $3965.6440 |
| 52-week low | $3706.2093 |
| Median price | $3708.9234 |
| Average price | $3748.7930 |
| Largest weekly change | +7.0% (Jan 14, 2026) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
The current National Average Drug Acquisition Cost (NADAC) for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES, manufactured by Novartis Pharmaceuticals Corporation, is $3924.3531 per ML (NDC 00078063998), effective Aug 19, 2026.
How has the price of COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES changed over time?
Over the history we have for it, the NADAC for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES has risen 9.6%. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
Since Jun 19, 2024, the NADAC for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES has ranged from a low of $3579.9043 (Jun 19, 2024) to a high of $3965.6440 (Jul 15, 2026), with a median of $3708.9234 per ML.
Are there cheaper alternatives to COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES in a comparable dosage form, but none are currently priced below it.
Who manufactures COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES (NDC 00078063998) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.